Joey Studts

Boehringer Ingelheim (Germany)

Papers

1

Total Citations

27

H-Index

1

About

Joey Studts is a leading figure in biopharmaceutical process development, whose work is central to the modernization of drug manufacturing. His research focuses on the application of process analytical technologies (PAT), particularly Raman spectroscopy, to enable real-time, in-line monitoring of critical quality attributes during production. His most-cited work, a 2023 study on computational Raman spectroscopy, has already garnered 27 citations, highlighting its immediate impact on the field. This research directly addresses pressing challenges in the industry—improving clinical consistency, satisfying evolving regulatory expectations for quality-by-design, and reducing manufacturing costs. By demonstrating how advanced spectroscopic data can be integrated with computational models to predict product quality in real time, Studts is helping to shift the industry away from traditional, end-point testing toward a more agile, continuous manufacturing paradigm. His contributions are not merely academic; they offer a practical roadmap for deploying PAT in commercial settings, making him a key voice in the conversation about the future of biotherapeutics production.

Research Focus

Key Achievements

1
H-Index
1
Papers
27
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
In-line product quality monitoring during biopharmaceutical manufacturing using computational Raman spectroscopy
27 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Boehringer Ingelheim (Germany)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago